We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · May 08, 2021

Incidence of AML and Myelodysplastic Syndrome in Patients With IBD and Impact of Thiopurines on Risk

The American Journal of Gastroenterology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The American Journal of Gastroenterology
Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk
Am. J. Gastroenterol 2021 Apr 01;116(4)741-747, N Khan, D Patel, C Trivedi, H Kavani, T Pernes, E Medvedeva, J Lewis, D Xie, YX Yang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading